Nicole S. Verkaik - Search Results

Year	Number of Results
2002	4
2003	3
2004	1
2005	1
2006	2
2007	1
2008	2
2009	5
2010	1
2014	1
2015	2
2016	2
2018	1
2019	2
2020	1
2021	2
2022	4
2023	4
2024	1

1

DNA-PKcs inhibitors sensitize neuroendocrine tumor cells to peptide receptor radionuclide therapy in vitro and in vivo.

Reuvers TGA, Verkaik NS, Stuurman D, de Ridder C, Groningen MCC, de Blois E, Nonnekens J. Reuvers TGA, et al. Among authors: verkaik ns. Theranostics. 2023 May 21;13(10):3117-3130. doi: 10.7150/thno.82963. eCollection 2023. Theranostics. 2023. PMID: 37351169 Free PMC article.

2

Functional Ex Vivo Tissue-Based Chemotherapy Sensitivity Testing for Breast Cancer.

Ladan MM, Meijer TG, Verkaik NS, Komar ZM, van Deurzen CHM, den Bakker MA, Kanaar R, van Gent DC, Jager A. Ladan MM, et al. Among authors: verkaik ns. Cancers (Basel). 2022 Feb 28;14(5):1252. doi: 10.3390/cancers14051252. Cancers (Basel). 2022. PMID: 35267560 Free PMC article.

3

In Vivo Efficacy Testing of Peptide Receptor Radionuclide Therapy Radiosensitization Using Olaparib.

Feijtel D, Reuvers TGA, van Tuyll-van Serooskerken C, de Ridder CMA, Stuurman DC, de Blois E, Verkaik NS, de Bruijn P, Koolen SLW, de Jong M, Nonnekens J. Feijtel D, et al. Among authors: verkaik ns. Cancers (Basel). 2023 Feb 1;15(3):915. doi: 10.3390/cancers15030915. Cancers (Basel). 2023. PMID: 36765883 Free PMC article.

4

Rapid recruitment of p53 to DNA damage sites directs DNA repair choice and integrity.

Wang YH, Ho TLF, Hariharan A, Goh HC, Wong YL, Verkaik NS, Lee MY, Tam WL, van Gent DC, Venkitaraman AR, Sheetz MP, Lane DP. Wang YH, et al. Among authors: verkaik ns. Proc Natl Acad Sci U S A. 2022 Mar 8;119(10):e2113233119. doi: 10.1073/pnas.2113233119. Epub 2022 Mar 2. Proc Natl Acad Sci U S A. 2022. PMID: 35235448 Free PMC article.

5

Functional RECAP (REpair CAPacity) assay identifies homologous recombination deficiency undetected by DNA-based BRCAness tests.

Meijer TG, Nguyen L, Van Hoeck A, Sieuwerts AM, Verkaik NS, Ladan MM, Ruigrok-Ritstier K, van Deurzen CHM, van de Werken HJG, Lips EH, Linn SC, Memari Y, Davies H, Nik-Zainal S, Kanaar R, Martens JWM, Cuppen E, Jager A, van Gent DC. Meijer TG, et al. Among authors: verkaik ns. Oncogene. 2022 Jun;41(26):3498-3506. doi: 10.1038/s41388-022-02363-1. Epub 2022 Jun 3. Oncogene. 2022. PMID: 35662281 Free PMC article.

6

Inter and intra-tumor somatostatin receptor 2 heterogeneity influences peptide receptor radionuclide therapy response.

Feijtel D, Doeswijk GN, Verkaik NS, Haeck JC, Chicco D, Angotti C, Konijnenberg MW, de Jong M, Nonnekens J. Feijtel D, et al. Among authors: verkaik ns. Theranostics. 2021 Jan 1;11(2):491-505. doi: 10.7150/thno.51215. eCollection 2021. Theranostics. 2021. PMID: 33391488 Free PMC article.

7

Preclinical Assessment of the Combination of PSMA-Targeting Radionuclide Therapy with PARP Inhibitors for Prostate Cancer Treatment.

Ruigrok EAM, Verkaik NS, de Blois E, de Ridder C, Stuurman D, Roobol SJ, Van Gent DC, de Jong M, Van Weerden WM, Nonnekens J. Ruigrok EAM, et al. Among authors: verkaik ns. Int J Mol Sci. 2022 Jul 21;23(14):8037. doi: 10.3390/ijms23148037. Int J Mol Sci. 2022. PMID: 35887398 Free PMC article.

8

Proof-of-concept study linking ex vivo sensitivity testing to neoadjuvant anthracycline-based chemotherapy response in breast cancer patients.

Ladan MM, Meijer TG, Verkaik NS, de Monye C, Koppert LB, Oomen-de Hoop E, van Deurzen CHM, Kanaar R, Nonnekens J, van Gent DC, Jager A. Ladan MM, et al. Among authors: verkaik ns. NPJ Breast Cancer. 2023 Sep 30;9(1):80. doi: 10.1038/s41523-023-00583-6. NPJ Breast Cancer. 2023. PMID: 37777518 Free PMC article.

9

Ex Vivo Functional Assay for Evaluating Treatment Response in Tumor Tissue of Head and Neck Squamous Cell Carcinoma.

Capala ME, Pachler KS, Lauwers I, de Korte MA, Verkaik NS, Mast H, Jonker BP, Sewnaik A, Hardillo JA, Keereweer S, Monserez D, Koljenovic S, Mostert B, Verduijn GM, Petit S, van Gent DC. Capala ME, et al. Among authors: verkaik ns. Cancers (Basel). 2023 Jan 12;15(2):478. doi: 10.3390/cancers15020478. Cancers (Basel). 2023. PMID: 36672427 Free PMC article.

10

C-Terminal Extensions of Ku70 and Ku80 Differentially Influence DNA End Binding Properties.

Inagawa T, Wennink T, Lebbink JHG, Keijzers G, Florea BI, Verkaik NS, van Gent DC. Inagawa T, et al. Among authors: verkaik ns. Int J Mol Sci. 2020 Sep 14;21(18):6725. doi: 10.3390/ijms21186725. Int J Mol Sci. 2020. PMID: 32937838 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

36 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

36 results

Results by year